UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000029473
Receipt No. R000033591
Scientific Title Systematic Screening for Atrial Fibrillation-potential Patients to Increase AF Detection Rate (SCAN-AF)
Date of disclosure of the study information 2017/10/10
Last modified on 2019/04/11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Systematic Screening for Atrial Fibrillation-potential Patients to Increase AF Detection Rate (SCAN-AF)
Acronym Screening for Atrial Fibrillation(AF)-potential Patients to Increase AF Detection Rate (SCAN-AF)
Scientific Title Systematic Screening for Atrial Fibrillation-potential Patients to Increase AF Detection Rate (SCAN-AF)
Scientific Title:Acronym Screening for Atrial Fibrillation(AF)-potential Patients to Increase AF Detection Rate (SCAN-AF)
Region
Japan

Condition
Condition Atrial Fibrillation
Classification by specialty
Cardiology Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine the prevalence of all (prevalent and paroxysmal) undiagnosed AF in a Japanese population
Basic objectives2 Others
Basic objectives -Others 1)The detection rate of undiagnosed prevalent AF
2)The detection rate of PAF
3)The number of subjects with AF identified by the 9200T and by the MB or HCG-801 during extended screening in subjects who did not have AF identified by ECG at their index visit
4)The proportion of screen-detected AF patients prescribed guideline-recommended anticoagulation therapy
5)The proportion of screen-detected PAF patients prescribed guideline-recommended anticoagulation therapy
6)The proportion of screen-detected AF patients adhering to guideline-recommended anticoagulation at the end of the 24w follow up(FU) period
7)The proportion of screen-detected AF patients adhering to guideline-recommended anticoagulation at the end of the 24w FU period
8)The proportion of screen-detected AF patients who had an ischemic stroke and/or bleeding during the 24w FU period
9)The proportion of screen-detected PAF patients who had an ischemic stroke and/or bleeding the 24w FU period
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The detection rate of prevalence of all (prevalent and paroxysmal) undiagnosed atrial fibrillation (AF) in a Japanese population with moderate-to-high risk for stroke
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)65 years of age or older
and one or more of the following:
2)Hypertension, prior stroke or transient ischemic attack, congestive heart failure, diabetes mellitus, and/or vascular disease
Key exclusion criteria 1)Younger than 65 years
2)Individuals with AF or a history of AF
3)Individuals taking anti-arrhythmic drugs
4)Individuals considered not suitable for participation by the investigator
5)Individuals who are not able use the monitoring devices properly and/or are unable to comply with the required procedures
Target sample size 1200

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ryoko Suzuki
Organization Bristol-Myers Squibb K.K.
Division name Cardiovascular Medical
Zip code
Address Shinjuku i-Land Tower, 5-1, Nishi-Shinjuku 6-chome, Shinjuku-ku, Tokyo 163-1328 Japan
TEL 03-6705-7000
Email Ryoko.Suzuki@bms.com

Public contact
Name of contact person
1st name
Middle name
Last name Yasuzumi Shimizu
Organization Quintiles Transnational Japan K.K.
Division name Real World & Late Phase Research
Zip code
Address 3-4-30 Miyahara, Yodogawa-ku, Osaka 532-0003 Japan
TEL 080-4409-9223
Homepage URL
Email Tadakazu.Inoue@quintiles.com

Sponsor
Institute Bristol-Myers Squibb K.K.
Institute
Department

Funding Source
Organization Bristol-Myers Squibb K.K.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 10 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2017 Year 03 Month 10 Day
Date of IRB
2017 Year 09 Month 12 Day
Anticipated trial start date
2017 Year 10 Month 10 Day
Last follow-up date
2019 Year 05 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information 1)Observational period:24w
2)Only the patients providing the informed consent will be registered.

Management information
Registered date
2017 Year 10 Month 09 Day
Last modified on
2019 Year 04 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033591

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.